Analysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activity

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCORDEIRO, R. A.
dc.contributor.authorFISCHER, F. M.
dc.contributor.authorSHINJO, S. K.
dc.date.accessioned2022-04-19T12:56:13Z
dc.date.available2022-04-19T12:56:13Z
dc.date.issued2022
dc.description.abstractObjective To compare the perception of disease activity (DA) between adult patients with systemic autoimmune myopathies (SAMs) and their physicians, and analyse possible sources of discordance. Methods This cross-sectional study included 75 patients with SAMs. Patients and physicians rated the global DA on a 0-10 cm visual analogue scale. A discrepancy score was calculated by subtracting physician assessment from patient assessment. Three groups were defined: (I) no discrepancy: difference within-2.0 to +2.0; (II) negative discrepancy (ND): difference <-2.0 (patient underrated DA in relation to physcian); (III) positive discrepancy (PD): difference >+2.0 (patient overrated DA in relation to physician). Logistic regression was used to identify predictors of discordance. Results Discordance in patient-physician assessment of DA was found in 21 (28%) cases. ND was observed in 3 (4%), PD in 18 (24%), and no discrepancy in 54 (72%) assessments. Due to the small number, ND cases were excluded from the analysis. PD was associated with older age, personal history of depression, past joint involvement, higher MMT-8 and lower extramuscular DA. In the regression model, for each additional year of age, the chance of PD increases, on average, by 9% (OR 1.09; 95%CI 1.01-1.17, p=0.034). Personal history of depression increases the chance of PD by 829% (OR 9.29; 95%CI 1.52-56.89, p=0.016). Conclusion Almost 30% of patients had discordance in DA assessment from their physicians. The majority of them overrated their DA. These patients tend to be older and are more likely to have personal history of depression, past joint involvement, and milder disease.eng
dc.description.indexPubMedeng
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2019/11776-6]
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [303379/2018-9]
dc.description.sponsorshipFaculdade de Medicina da USP
dc.identifier.citationCLINICAL AND EXPERIMENTAL RHEUMATOLOGY, v.40, n.2, p.339-345, 2022
dc.identifier.doi10.55563/CLINEXPRHEUMATOL/KEIEDV
dc.identifier.eissn1593-098X
dc.identifier.issn0392-856X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/45826
dc.language.isoeng
dc.publisherCLINICAL & EXPER RHEUMATOLOGYeng
dc.relation.ispartofClinical and Experimental Rheumatology
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright CLINICAL & EXPER RHEUMATOLOGYeng
dc.subjectdermatomyositiseng
dc.subjectpolymyositiseng
dc.subjectmyositiseng
dc.subjectself-assessmenteng
dc.subjectvisual analogue scaleeng
dc.subjectpatient-reported outcome measureseng
dc.subjecthealth statuseng
dc.subject.otheroutcome assessmenteng
dc.subject.otherclassificationeng
dc.subject.otheradulteng
dc.subject.otherdiscordanceeng
dc.subject.otherseverityeng
dc.subject.otherdermatomyositiseng
dc.subject.otherdeterminantseng
dc.subject.otherpolymyositiseng
dc.subject.wosRheumatologyeng
dc.titleAnalysis of patient-physician discrepancy in global assessment of systemic autoimmune myopathy disease activityeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalFISCHER, F. M.:Univ Sao Paulo, Fac Saude Publ, Dept Environm Hlth, Sao Paulo, SP, Brazil
hcfmusp.citation.scopus4
hcfmusp.contributor.author-fmusphcRAFAEL ALVES CORDEIRO
hcfmusp.contributor.author-fmusphcSAMUEL KATSUYUKI SHINJO
hcfmusp.description.beginpage339
hcfmusp.description.endpage345
hcfmusp.description.issue2
hcfmusp.description.volume40
hcfmusp.origemWOS
hcfmusp.origem.pubmed35200134
hcfmusp.origem.scopus2-s2.0-85125549913
hcfmusp.origem.wosWOS:000762805800019
hcfmusp.publisher.cityPISAeng
hcfmusp.publisher.countryITALYeng
hcfmusp.relation.referenceAlarcon GS, 2002, ARTHRIT RHEUM-ARTHR, V47, P408, DOI 10.1002/art.10512eng
hcfmusp.relation.referenceAllenbach Y, 2018, NEUROMUSCULAR DISORD, V28, P87, DOI 10.1016/j.nmd.2017.09.016eng
hcfmusp.relation.referenceBarton JL, 2010, ARTHRIT CARE RES, V62, P857, DOI 10.1002/acr.20132eng
hcfmusp.relation.referencePinto GLB, 2020, CLIN RHEUMATOL, V39, P2763, DOI 10.1007/s10067-020-05013-7eng
hcfmusp.relation.referenceGuimaraes MFBR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230317eng
hcfmusp.relation.referenceCatalan M, 2014, AUTOIMMUN REV, V13, P363, DOI 10.1016/j.autrev.2014.01.016eng
hcfmusp.relation.referenceChalla DN, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1419-5eng
hcfmusp.relation.referenceDesthieux C, 2016, ARTHRIT CARE RES, V68, P1767, DOI 10.1002/acr.22902eng
hcfmusp.relation.referenceDiRenzo D, 2019, CURR RHEUMATOL REP, V21, DOI 10.1007/s11926-019-0862-5eng
hcfmusp.relation.referenceEder L, 2015, ARTHRIT CARE RES, V67, P264, DOI 10.1002/acr.22401eng
hcfmusp.relation.referenceElefante E, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-02334-5eng
hcfmusp.relation.referenceElera-Fitzcarrald C, 2020, JCR-J CLIN RHEUMATOL, V26, pS165, DOI 10.1097/RHU.0000000000001267eng
hcfmusp.relation.referenceFeldon M, 2017, ARTHRIT CARE RES, V69, P1743, DOI 10.1002/acr.23198eng
hcfmusp.relation.referenceHarris-Love MO, 2009, RHEUMATOLOGY, V48, P134, DOI 10.1093/rheumatology/ken441eng
hcfmusp.relation.referenceJulian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561eng
hcfmusp.relation.referenceKhan NA, 2012, ARTHRIT CARE RES, V64, P206, DOI 10.1002/acr.20685eng
hcfmusp.relation.referenceLundberg IE, 2017, ARTHRITIS RHEUMATOL, V69, P2271, DOI 10.1002/art.40320eng
hcfmusp.relation.referenceMiller FW, 2001, RHEUMATOLOGY, V40, P1262, DOI 10.1093/rheumatology/40.11.1262eng
hcfmusp.relation.referenceNicolau G, 2004, J RHEUMATOL, V31, P1293eng
hcfmusp.relation.referenceOddis CV, 2018, NAT REV RHEUMATOL, V14, P279, DOI 10.1038/nrrheum.2018.42eng
hcfmusp.relation.referenceRider LG, 2004, ARTHRITIS RHEUM-US, V50, P2281, DOI 10.1002/art.20349eng
hcfmusp.relation.referenceRider LG, 2018, NAT REV RHEUMATOL, V14, P303, DOI 10.1038/nrrheum.2018.33eng
hcfmusp.relation.referenceRider LG, 2011, ARTHRIT CARE RES, V63, pS118, DOI 10.1002/acr.20532eng
hcfmusp.relation.referenceRider Lisa G., 2003, Journal of Rheumatology, V30, P603eng
hcfmusp.relation.referenceSmarr KL, 2011, ARTHRIT CARE RES, V63, pS454, DOI 10.1002/acr.20556eng
hcfmusp.relation.referenceSultan SM, 2008, ARTHRITIS RHEUM, V58, P3593, DOI 10.1002/art.23963eng
hcfmusp.relation.referenceTory H, 2020, PEDIATR RHEUMATOL, V18, DOI 10.1186/s12969-020-0402-xeng
hcfmusp.relation.referenceYen JC, 2003, J RHEUMATOL, V30, P1967eng
hcfmusp.relation.referenceZong M, 2011, NAT REV RHEUMATOL, V7, P297, DOI 10.1038/nrrheum.2011.39eng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationf421b597-58b1-4c89-9782-e83f57ee6a11
relation.isAuthorOfPublication07f179c5-58d8-4efe-832c-52095a9009d6
relation.isAuthorOfPublication.latestForDiscoveryf421b597-58b1-4c89-9782-e83f57ee6a11
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_CORDEIRO_Analysis_of_patientphysician_discrepancy_in_global_assessment_of_2022.PDF
Tamanho:
269.83 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - LIM/17